Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07344233
Eligibility Criteria:
Inclusion criteria:
* Ability to understand, give informed consent and perform the tasks
* males and females 18-64 years of age at the time of enrollment in the study
* DSM-5 diagnosis of opioid use disorder with heroin as the primary drug of choice
* currently enrolled in a treatment facility for heroin use as the primary concern
* 2-4 week abstinence from non-prescribed opioid use/stabilized on medication assisted therapy (MAT) using either methadone and/or buprenorphine.
Exclusion criteria:
* present or past history of a neurodevelopmental, neurological, or a psychotic disorder
* head trauma with loss of consciousness for more than 30 min
* use of medications (current or in the last 6 months) with known CNS effects which may alter cerebral function, with the exception of psychotropics for the treatment of pain/depression/anxiety/PTSD (e.g. SSRIs) or as otherwise determined by the Principle Investigator
* current medical illness and/or evident infection
* being pregnant or nursing
* contraindications to the MRI environment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT07344233
Study Brief:
Protocol Section:
NCT07344233